Jr, W., Robinson, B., Gagel, R., Dralle, H., Fagin, J., Santoro, M., . . . Schlumberger, M. (2012). Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply.
Cita Chicago (17th ed.)Jr, W., et al. Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply. 2012.
Cita MLA (9th ed.)Jr, W., et al. Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply. 2012.
Atenció: Aquestes cites poden no estar 100% correctes.